[ad_1]
Key Points
- Dawn Christine Maroney, President of Alignment Healthcare, sold 215,662 shares at an average price of $16.41, totaling approximately $3.54 million, which represents a 10.71% decrease in her position.
- Alignment Healthcare’s stock has a market cap of $3.26 billion and reported a 49% revenue increase in the last quarter, with earnings beating the consensus estimate.
- Recent analyst ratings have generally been positive, with a mix of upgrades and a current average target price of $18.83 for the stock.
Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) insider Robert Scavo sold 29,535 shares of the stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $484,669.35. Following the completion of the sale, the insider directly owned 572,555 shares of the company’s stock, valued at $9,395,627.55. The trade was a 4.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Alignment Healthcare Stock Performance
NASDAQ:ALHC opened at $16.45 on Thursday. The firm’s fifty day simple moving average is $14.32 and its 200 day simple moving average is $15.47. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare, Inc. has a twelve month low of $8.82 and a twelve month high of $21.06. The firm has a market capitalization of $3.26 billion, a price-to-earnings ratio of -58.75 and a beta of 1.17.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same period last year, the company posted ($0.13) earnings per share. The firm’s revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on ALHC shares. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target for the company in a report on Monday, August 25th. Stephens upgraded shares of Alignment Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, Zacks Research raised shares of Alignment Healthcare to a “hold” rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $18.83.
Read Our Latest Report on ALHC
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of ALHC. Wellington Management Group LLP grew its position in shares of Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after buying an additional 3,257,630 shares during the last quarter. Millennium Management LLC boosted its stake in Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock valued at $38,122,000 after acquiring an additional 2,896,311 shares during the period. Invesco Ltd. grew its holdings in shares of Alignment Healthcare by 122.3% during the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after purchasing an additional 2,294,739 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $20,087,000. Finally, Vanguard Group Inc. raised its position in shares of Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock worth $206,941,000 after purchasing an additional 1,295,825 shares during the period. 86.19% of the stock is currently owned by institutional investors.
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
[ad_2]
Source link
